Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì
  #1  
Ñòàðûé 12.08.2012, 00:51
healthy777 healthy777 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.08.2012
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 9
healthy777 *
Exclamation Ðàê ÿè÷êà?

Äîáðûé äåíü. Ìíå 32 ãîäà. Íåäàâíî ïðè ïàëüïàöèè îáíàðóæèë óïëîòíåíèå â ÿè÷êå. Îáðàòèëñÿ ê âðà÷ó.
ÓÇÈ âûÿâèëî íîâîîáðàçîâàíèå â ÿè÷êå ðàçìåðîì 19õ20 ìì. Ïîêàçàíèå: ãîñïèòàëèçàöèÿ, îðõèôóíèêóëýêòîìèÿ. Óäàëåíèå ÿè÷êà.

Ïûòàëñÿ âûÿñíèòü íåñêîëüêî âîïðîñîâ, íî òàê è íå ïîíÿë îêîí÷àòåëüíî.
1. Ýòî îäíîçíà÷íî ðàê ÿè÷êà? Âîçìîæíî ëè äîáðîêà÷åñòâåííîå îáðàçîâàíèå?
2.  ëþáîì ëè ñëó÷àå íåîáõîäèìî óäàëåíèå ÿè÷êà?
3. Êàêèå äîïîëíèòåëüíûå èññëåäîâàíèÿ íåîáõîäèìî ïðîâåñòè äëÿ ïîëíîé êàðòèíû?
Ñïàñèáî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 12.08.2012, 17:29
Àâàòàð äëÿ DoctorUro
DoctorUro DoctorUro âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 31.10.2009
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,996
Ñêàçàë(à) ñïàñèáî: 7
Ïîáëàãîäàðèëè 878 ðàç(à) çà 857 ñîîáùåíèé
DoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
1. Âåðîÿòíîñòü âåëèêà, íî îäíîçíà÷íûé îòâåò äàñò ãèñòîëîãè÷åñêîå èññëåäîâàíèå òêàíè îïóõîëè.
2. Åñëè ïîäîçðåíèå íà ðàê - äà. Ïîïðîáóéòå ïîëó÷èòü âòîðîå î÷íîå ìíåíèå ó îíêîóðîëîãà â ñïåöèàëèçèðîâàííîì ó÷ðåæäåíèè: èíñòèòóò Ãåðöåíà, îíêîöåíòð, 40, 62 áîëüíèöû - òàì, ãäå åñòü îíêîóðîëîãèÿ.
3. Åñòü ìàðêåðû ðàêà ÿè÷êà, íî îíè íå âñåãäà 100% èíôîðìàòèâíû: àëüôà-ôåòîïðîòåèí, ÕÃ× è ËÄÃ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 28.08.2012, 14:06
healthy777 healthy777 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.08.2012
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 9
healthy777 *
Ðåçóëüòàòû àíàëèçîâ:
ËÄÃ – 279* (125-220)
ÀÔÏ – 2,8 (äî 8)
ÕÃ× – 2,5 (äî 10)
ÐÝÀ – 1,6 (äî 2,5)

ÊÒ ñ êîíòðàñòîì: äàííûõ çà íàëè÷èå èçìåíåíèé â ëåãêèõ, ïàðåíõèìàòîçíûõ îðãàíàõ áðþøíîé ïîëîñòè, äàííûõ çà óâåëè÷åíèå âíóòðèãðóäíûõ è çàáðþøèííûõ ëèìôîóçëîâ íå ïîëó÷åíî.

22.08 ïðîèçâåäåíî óäàëåíèå ÿè÷êà ñ êàíàòèêîì.

Ãèñòîëîãèÿ:
Òèïè÷íàÿ ñåìèíîìà ÿè÷êà. Î÷àãè íåêðîçà îïóõîëè. Âíóòðèêàíàëüöåâîå ðàñïðîñòðàíåíèå ñåìèíîìû. Î÷àãè ãåðìèíîãåííîé âíóòðèêàíàëüöåâîé íåîïëàçèè â òêàíè ÿè÷êà. Ïðèçíàêè àíãèîëèìôàòè÷åñêîé èíâàçèè ñåìèíîìû íå îáíàðóæåíû. Îïóõîëü âðàñòàåò â áåëî÷íóþ îáîëî÷êó ÿè÷êà, íî íå ïðîðàñòàåò â íåå. Íå îáíàðóæåíî âðàñòàíèÿ îïóõîëè â ëèñòêè âëàãàëèùíîé îáîëî÷êè ÿè÷êà, ïðèäàòîê ÿè÷êà, ñåìåííîé êàíàòèê. Ïî êðàþ ðåçåêöèè ñåìåííîãî êàíàòèêà ðàêîâûå êëåòêè íå îáíàðóæåíû.

Ñåé÷àñ ñòîèò âîïðîñ î äàëüíåéøåì ëå÷åíèè. Ëå÷àùèé âðà÷ ãîâîðèò, ÷òî â ìîåì ñëó÷àå (êëàññè÷åñêàÿ ñåìèíîìà 1 ñò.) îáû÷íî íèêàêîãî äîïîëíèòåëüíîãî ëå÷åíèÿ íå ïðîèçâîäèòñÿ, íî ïðåäëàãàåò ïðè ýòîì ïðîôèëàêòè÷åñêè õèìèîòåðàïèþ (1-2 êàïåëüíèöû), îáúÿñíÿÿ òåì, ÷òî åñëè ãäå-òî îñòàëàñü äàæå îäíà êëåòî÷êà åå íàäî óíè÷òîæèòü.
Âûáîð ñòîèò çà ìíîé. Ìíå, êîíå÷íî, ñëîæíî îïðåäåëèòüñÿ.
Óâàæàåìûå âðà÷è, äåéñòâèòåëüíî ëè ëå÷åíèå íå íóæíî? Èëè âñå æå íà ïðàêòèêå ïðîâîäÿò õèìèîòåðàïèþ ïðîôèëàêòè÷åñêè?
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 29.08.2012, 20:38
Àâàòàð äëÿ DoctorUro
DoctorUro DoctorUro âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 31.10.2009
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,996
Ñêàçàë(à) ñïàñèáî: 7
Ïîáëàãîäàðèëè 878 ðàç(à) çà 857 ñîîáùåíèé
DoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âðà÷ ïðàâ: äàæå ïðè 1 ñòàäèè ãàðàíòèðîâàòü òî, ÷òî îòñóòñòâóþò ìèêðîìåòàñòàçû, íèêòî íå ñìîæåò, ïîýòîìó äàæå ïðè ðàäèêàëüíî âûïîëíåííîé îïåðàöèè, êàê â Âàøåì ñëó÷àå, õèìèîòåðàïèÿ æåëàòåëüíà.
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 29.08.2012, 21:24
healthy777 healthy777 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.08.2012
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 9
healthy777 *
À êàêèå ñõåìû õèìèîòåðàïèè íàçíà÷àþòñÿ â òàêîì ñëó÷àå? Äåéñòâèòåëüíî ëè 1-2 êàïåëüíèö äîñòàòî÷íî?
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 29.08.2012, 22:46
Àâàòàð äëÿ FRSM
 FRSM  FRSM âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 12.06.2007
Ãîðîä: Airstrip One
Ñîîáùåíèé: 4,766
Ïîáëàãîäàðèëè 697 ðàç(à) çà 672 ñîîáùåíèé
FRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Seminoma of the testicle is exquisitely radiosensitive and post-surgical radiotherapy is a key part of the treatment approach. Retroperitoneal lymph node dissection is indicated in patients found to have limited metastatic spread in addition to radiotherapeutic treatment.
Chemotherapy is advocated in patients with advanced seminoma. Observation is an experimental approach in the post-operative management of early stage testicular seminoma but should be reserved for highly motivated individuals or as a research tool.

!!! It is important to offer semen cryopreservation to all men presenting with testicular carcinoma prior to the commencement of therapy should they wish to preserve fertility. Improvement in symptoms is an important measurement.

Êîììåíòàðèè ê ñîîáùåíèþ:
DoctorUro îäîáðèë(à): ñïàñèáî! *ñ âîçâðàùåíèåì!
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 29.08.2012, 22:47
Àâàòàð äëÿ FRSM
 FRSM  FRSM âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 12.06.2007
Ãîðîä: Airstrip One
Ñîîáùåíèé: 4,766
Ïîáëàãîäàðèëè 697 ðàç(à) çà 672 ñîîáùåíèé
FRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
External beam radiotherapy for stage I and nonbulky stage II disease
Refer patients with stage I and nonbulky stage II seminomas for external beam radiotherapy. Over a 3-week period, administer 2500 cGy in a hockey-stick field, including the para-aortic, paracaval, bilateral common iliac, and external iliac nodal regions. Recent protocols are reducing the radiation field to the para-aortic area only.
A 2005 randomized trial from the Medical Research Council compared adjuvant radiotherapy at 30 Gy versus 20 Gy for stage I seminoma. The lower dose resulted in equivalent associated relapse rates and reduced morbidity, especially regarding fatigue. Further follow-up was recommended to determine if associated long-term secondary malignancies develop.[23]
Mediastinal radiation was commonly administered but is currently avoided because chemotherapy is more effective. Mediastinal radiation may also diminish the ability to provide salvage chemotherapy later, if needed.
Only 3% of patients relapse after radiation therapy. Relapses are usually located outside the radiation field.
Short-term adverse effects include fatigue, nausea, vomiting, and GI upset.
Long-term adverse effects have become of more concern over the last several years. Zagars and colleagues (2004) published a review of all patients who underwent radiotherapy postorchiectomy for seminoma between 1951 and 1999. They then computed standardized mortality ratios based on the person-years method. They found an increased risk after 15 years for cardiovascular and secondary cancer mortalities and recommended investigating new therapies that do not confer these long-term effects.[24] Gamulin et al recommend cytogenetic screening as a way to detect high-risk individuals and thereby regularly monitor seminoma patients after the successful therapy.[25]
As an alternative to radiotherapy, single-agent carboplatin protocols are being studied. The Medical Research Council compared adjuvant carboplatin with radiotherapy and found equivalent relapse rates after a median follow-up period of 4 years. Long-term success of carboplatin therapy is unknown so should be considered experimental at this time.[26]
Chemotherapy for stage II bulky or stage III disease
After radical orchiectomy (see Surgical Care) and metastatic workup, administer 4 cycles of chemotherapy without radiotherapy in patients with advanced seminoma (stage IIB bulky or stage III).[27]
Clinical trials have evaluated numerous chemotherapeutic regimens. While the optimal regimen is debatable, 4 cycles of bleomycin, etoposide, and cisplatin (BEP) is standard.
Ongoing clinical trials are evaluating the omission of the fourth cycle, or bleomycin, in low-risk patients.
For poor-risk and salvage cases, physicians may use alternative regimens using ifosfamide and vinblastine with dose escalation.

Êîììåíòàðèè ê ñîîáùåíèþ:
Melnichenko îäîáðèë(à): ðàäà íîâîé âñòðå÷å !
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 29.08.2012, 23:37
healthy777 healthy777 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.08.2012
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 9
healthy777 *
Ñ ïåðåâîäîì ñëîæíîñòè, íî ñóòü, êàæåòñÿ óëîâèë.
Íàøåë äîêóìåíò íà ðóññêîì ÿçûêå, öèòèðóþ îòòóäà ðåçþìå:

Ðåêîìåíäàöèè ïî ëå÷åíèþ ñåìèíîìû ñòàäèè I
1. Íàáëþäåíèå (ïðè íàëè÷èè òåõíè÷åñêèõ âîçìîæíîñòåé è ñîãëàñèè ïàöèåíòà ñëåäîâàòü âðà÷åáíûì ðåêîìåíäàöèÿì) (óðîâåíü ðåêîìåíäàöèè Â).
2. Õèìèîòåðàïèÿ êàðáîïëàòèíîì (1 êóðñ â äîçå AUC 7) ìîæåò áûòü ðåêîìåíäîâàíà êàê àëüòåðíàòèâà ëó÷åâîé òåðàïèè è íàáëþäåíèþ (óðîâåíü ðåêîìåíäàöèè À).
3. Àäúþâàíòíàÿ ëó÷åâàÿ òåðàïèÿ íà ïàðààîðòàëüíóþ çîíó èëè ïîëå â ôîðìå «õîêêåéíîé êëþøêè» äî ÑÎÄ 20 Ãð (óðîâåíü ðåêîìåíäàöèè À).

Ñóòü òà æå? Óðîâåíü ðåêîìåíäàöèè À - ýòî íàèáîëåå ïðåäïî÷òèòåëüíî, ÿ ïðàâèëüíî ïîíÿë?
Ñïàñèáî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #9  
Ñòàðûé 30.08.2012, 00:43
Àâàòàð äëÿ FRSM
 FRSM  FRSM âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 12.06.2007
Ãîðîä: Airstrip One
Ñîîáùåíèé: 4,766
Ïîáëàãîäàðèëè 697 ðàç(à) çà 672 ñîîáùåíèé
FRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Äëÿ Âàøåãî ñïåöèàëèñòà:

According to the published data,
chemotherapy as adjuvant therapy for clinical
stage I seminoma (Table 4) provides a valid
alternative to radiotherapy. A number of
therapeutic regimens have been described
that differ with regard to the dosage [21] and
number of cycles (one or two),,,,,

In conclusion, in patients with clinical stage I
seminoma of the testis, two cycles of
carboplatin monotherapy comprises an
oncologically effective and well tolerated
treatment modality. Despite the lack of a
randomized trial, the data available in the
literature suggest that the administration of
two cycles instead of one cycle could lead to a
reduction in recurrence rates of ≈50%. Long
term follow-up of the contralateral testicle is
recommended.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Îòâåòèòü ñ öèòèðîâàíèåì
  #10  
Ñòàðûé 30.08.2012, 01:28
healthy777 healthy777 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.08.2012
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 9
healthy777 *
Îñòàåòñÿ òîëüêî íàäåÿòüñÿ, ÷òî ìîé âðà÷ çíàåò àíãëèéñêèé â ñîâåðøåíñòâå)
ß òàê ïîíÿë, ÷òî íóæíî 2 êóðñà êàðáîïëàòèíà, âìåñòî îäíîãî, ñïàñèáî ãóãë-ïåðåâîä÷èêó. ×òî-æ, îáñóäèì ýòî ñ âðà÷îì.
Ñïàñèáî.
Ñ óâàæåíèåì.
Îòâåòèòü ñ öèòèðîâàíèåì
  #11  
Ñòàðûé 31.08.2012, 21:40
healthy777 healthy777 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.08.2012
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 9
healthy777 *
Íàçíà÷èëè ìíå 2 êóðñà êàðáîïëàòèíà.
Ïàðàëëåëüíî íà÷èòàëñÿ èíôîðìàöèè î ïîáî÷êàõ õèìèè... ñòàëî ñòðàøíî. Ïàäàåò èììóíèòåò, îãðîìíàÿ íàãðóçêà íà ïî÷êè è ò.ï. ðàäîñòè. Ïîíèìàþ, ÷òî ðàê áîëåå ñòðàøåí, íî íå ïîíèìàþ âîò ÷åãî.  ñòàíäàðòàõ ëå÷åíèÿ íàïèñàíî, ÷òî äàæå ïðè äèíàìè÷åñêîì íàáëþäåíèè ìîåãî ñëó÷àÿ âûæèâàåìîñòü 97-100%. Òàê âîò, à â ñëó÷àå ïðîâåäåíèÿ õèìèè íåóæåëè áîëüøå? Áîëüøå òî íåêóäà. Åñëè âûáðàòü ñåé÷àñ âñå-òàêè äèíàìè÷åñêîå íàáëþäåíèå, è ïðîâåñòè õèìèþ óæå â ñëó÷àå âîçíèêíîâåíèÿ ìåòàñòàç, ÷òî ýòî èçìåíèò? Ïî÷åìó íåïðèåìëåì ýòîò âàðèàíò?
Ñïàñèáî. È ïðîøó ïðîùåíèÿ çà äîòîøíîñòü
Îòâåòèòü ñ öèòèðîâàíèåì
  #12  
Ñòàðûé 31.08.2012, 22:03
Àâàòàð äëÿ FRSM
 FRSM  FRSM âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 12.06.2007
Ãîðîä: Airstrip One
Ñîîáùåíèé: 4,766
Ïîáëàãîäàðèëè 697 ðàç(à) çà 672 ñîîáùåíèé
FRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âàðèàíò ïîëíîñòüþ ïðèåìëeì; áîëüøîå êîëè÷åñòâî ïàöèåíòîâ ñ ïåðâîé ñòàäèåé ïðåäïî÷èòàþò "wathchful waiting":

If you have stage 1 testicular cancer, surgery is often the only treatment you'll need. If your doctor thinks you're likely to have been totally cured by your operation, he or she may suggest watchful waiting. This is when you have regular check-ups rather than more treatment.

This means you avoid the side effects of radiotherapy and chemotherapy. But you do run a higher risk of your cancer coming back. However, if your cancer does come back, you'll still be able to have treatment to get rid of it.

It may be more important for you to avoid the side effects of radiotherapy and chemotherapy. Or you may be more concerned about making sure your cancer doesn't come back. Your doctor will be able to give you advice, but the final decision will be yours. It may help to remember that men who have regular check-ups, and more treatment later if they need it, live just as long as men who have more treatment straight away.
Îòâåòèòü ñ öèòèðîâàíèåì
  #13  
Ñòàðûé 31.08.2012, 23:09
healthy777 healthy777 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.08.2012
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 9
healthy777 *
Ñóùåñòâóåò ëè íàèáîëåå ðåêîìåíäóåìûé è äîêàçàííûé âàðèàíò ñ ó÷åòîì ðèñêîâ âîçíèêíîâåíèÿ ïîñëåäñòâèé õèìèîòåðàïèè è ðèñêà ðåöèäèâà áåç íåå, èëè ýòî âûáîð ïàëüöåì â íåáî?
Îòâåòèòü ñ öèòèðîâàíèåì
  #14  
Ñòàðûé 12.09.2012, 15:07
healthy777 healthy777 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.08.2012
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 16
Ñêàçàë(à) ñïàñèáî: 9
healthy777 *
Äîáðûé äåíü âñåì! Ïðîøåë êóðñ êàðáîïëàòèíà 600 ìã, â öåëîì ïåðåíåñ íîðìàëüíî, ñëàáîñòü 4 äíÿ, îæèë. Ñïàñèáî îãðîìíîå çà êîíñóëüòàöèè, î÷åíü ïîìîãëî ñäåëàòü âûáîð â ëå÷åíèè.
Íà äàííûé ìîìåíò ñòîèò âîïðîñ äàëüíåéøåãî îáñëåäîâàíèÿ. Õèðóðã âîîáùå ñêàçàë - òåïåðü ÷åðåç ãîä ÊÒ è îíêîìàðêåðû.  îíêîäèñïàíñåðå ïðè ïîñòàíîâêå íà ó÷åò âðà÷ ñêàçàë, ÷òî òåïåðü êàæäûé òðè ìåñÿöà ÊÒ.  ñåòè òî÷íóþ èíôîðìàöèþ íå ìîãó íàéòè. Ïîäñêàæèòå ïîæàëóéñòà, êàêàÿ ñõåìà íàáëþäåíèÿ ïîêàçàíà â ìîåì ñëó÷àå?
ÑÏàñèáî!
Îòâåòèòü ñ öèòèðîâàíèåì
  #15  
Ñòàðûé 12.09.2012, 22:16
Àâàòàð äëÿ DoctorUro
DoctorUro DoctorUro âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 31.10.2009
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,996
Ñêàçàë(à) ñïàñèáî: 7
Ïîáëàãîäàðèëè 878 ðàç(à) çà 857 ñîîáùåíèé
DoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDoctorUro ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Îáû÷íî ïåðâûé ãîä ÊÒ äåëàåòñÿ ÷àùå: ïåðâîå - ÷åðåç 3 ìåñÿöà ïîñëå îïåðàöèè, ïîòîì îäíî - äâà êàæäûå ïîëãîäà (çàâèñèò åùå îò òîãî, ÷òî íà ïðåäûäóùèõ). Åñëè âñå õîðîøî - äàëåå ðàç â ãîä äî 5 ëåò. Ìîæåò áûòü íàçíà÷åíà èíäèâèäóàëüíàÿ ñõåìà îáñëåäîâàíèÿ íà óñìîòðåíèå âðà÷à.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò


Îïöèè òåìû Ïîèñê â ýòîé òåìå
Ïîèñê â ýòîé òåìå:

Ðàñøèðåííûé ïîèñê
Îïöèè ïðîñìîòðà

Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 13:08.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.